Screening and detection of hepatocellular carcinoma.
作者： Heather N. Simpson , Brendan M. McGuire
DOI: 10.1016/J.CLD.2015.01.004
关键词:
摘要: The increasing incidence of hepatocellular carcinoma (HCC) has led to the need identify patients at risk for HCC so that a program screening can be undertaken. Screening earlier diagnosis tumors and thus aided in initiating optimal medical treatment disease course. Advances radiological techniques identification more accurate serum tests diagnose continue important areas study exploration. In particular, there have been efforts develop new tumor markers aid guide therapy tumors.
elsevier.com
sci-hub.se 参考文章(83)
François Durand, Jean Marc Regimbeau, Jacques Belghiti, Alain Sauvanet, Valérie Vilgrain, Benoı̂t Terris, Vincent Moutardier, Olivier Farges, Dominique Valla, Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma Journal of Hepatology. ,vol. 35, pp. 254- 258 ,(2001) , 10.1016/S0168-8278(01)00108-8
Jorge A. Marrero, Ziding Feng, Yinghui Wang, Mindie H. Nguyen, Alex S. Befeler, Lewis R. Roberts, K. Rajender Reddy, Denise Harnois, Josep M. Llovet, Daniel Normolle, Jackie Dalhgren, David Chia, Anna S. Lok, Paul D. Wagner, Sudhir Srivastava, Myron Schwartz, α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma Gastroenterology. ,vol. 137, pp. 110- 118 ,(2009) , 10.1053/J.GASTRO.2009.04.005
Valérie Paradis, Francoise Degos, Delphine Dargère, Nanou Pham, Jacques Belghiti, Claude Degott, Jean-Louis Janeau, Annie Bezeaud, Dominique Delforge, Myriam Cubizolles, Ingrid Laurendeau, Pierre Bedossa, Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology. ,vol. 41, pp. 40- 47 ,(2005) , 10.1002/HEP.20505
Bruno Daniele, Alfonso Bencivenga, Angelo Salomone Megna, Vincenza Tinessa, α-fetoprotein and ultrasonography screening for hepatocellular carcinoma Gastroenterology. ,vol. 127, pp. 108- 112 ,(2004) , 10.1053/J.GASTRO.2004.09.023
Richard K. Sterling, Lennox Jeffers, Fredric Gordon, Morris Sherman, Alan P. Venook, K. Rajender Reddy, Shinji Satomura, Myron E. Schwartz, Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis. The American Journal of Gastroenterology. ,vol. 102, pp. 2196- 2205 ,(2007) , 10.1111/J.1572-0241.2007.01405.X
Anna S Lok, Richard K Sterling, James E Everhart, Elizabeth C Wright, John C Hoefs, Adrian M Di Bisceglie, Timothy R Morgan, Hae–Young Kim, William M Lee, Herbert L Bonkovsky, Jules L Dienstag, Halt-C Trial Group, Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma Gastroenterology. ,vol. 138, pp. 493- 502 ,(2010) , 10.1053/J.GASTRO.2009.10.031
Xavier Forns, Sergi Ampurdanès, Josep M. Llovet, John Aponte, Llorenç Quintó, Eva Martínez-Bauer, Miquel Bruguera, Jose Maria Sánchez-Tapias, Juan Rodés, Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology. ,vol. 36, pp. 986- 992 ,(2002) , 10.1053/JHEP.2002.36128
David Naimark, Gary Naglie, Allan S. Detsky, The meaning of life expectancy Journal of General Internal Medicine. ,vol. 9, pp. 702- 707 ,(1994) , 10.1007/BF02599016
Kazuhiro Nouso, Hironori Tanaka, Shuji Uematsu, Kunihiro Shiraga, Ryoichi Okamoto, Hideki Onishi, Shin-ichiro Nakamura, Yoshiyuki Kobayashi, Yasuyuki Araki, Noriaki Aoki, Yasushi Shiratori, Cost‐effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances Journal of Gastroenterology and Hepatology. ,vol. 23, pp. 437- 444 ,(2008) , 10.1111/J.1440-1746.2007.05054.X
G Fattovich, G Giustina, G Realdi, R Corrocher, S W Schalm, , Long‐term outcome of hepatitis B e antigen–positive patients with compensated cirrhosis treated with interferon alfa Hepatology. ,vol. 26, pp. 1338- 1342 ,(1997) , 10.1002/HEP.510260536